Effectiveness of amino acid supplementation in preventing acute kidney injury following cardiac surgery: A systematic review and meta-analysis of randomized controlled trials
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Majeed, Mir WajidFinnegan, Emma
Gallo Ruelas, Mariano
Lopes, Lucca Moreira
Righetto, Bruno Branco
Salha, Issa
Delgado, Daniel
Quirós, Melissa Chacón
Tomo, Assaina Tatiana Jaquissone
Ahmad, Raheel
Andrabi, Suhaib
Abujaber, Samer
Issue Date
2025-07-01Keywords
acute kidney injuryamino acids
glomerular filtration rate
perioperative care
renal replacement therapy
Metadata
Show full item recordPublisher
John Wiley and Sons IncJournal
Acta Anaesthesiologica ScandinavicaDOI
https://doi.org/10.1111/aas.70037Abstract
Introduction: Acute kidney injury (AKI) is a frequent complication of cardiac surgery, contributing to increased morbidity, longer hospital stays, and higher mortality. Evidence suggests amino acid (AA) supplementation may enhance renal blood flow and glomerular filtration rate (GFR), potentially reducing AKI risk; however, findings remain inconclusive. This study evaluated the efficacy of perioperative AA supplementation in preventing AKI and related complications post-cardiac surgery. Methods: PubMed, Embase, and Cochrane databases were searched for randomized controlled trials (RCTs) comparing AA supplementation versus standard care in preventing cardiac surgery-associated AKI. Main outcomes included AKI incidence (defined by the Kidney Disease Improving Global Outcomes (KDIGO) criteria), 30-day mortality, and renal replacement therapy (RRT) requirement. Pooled risk ratios (RRs) with 95% confidence intervals (CIs) were calculated using random-effects models. Statistical significance was set at p < 0.05. The certainty of the evidence (CoE) was assessed using the GRADE approach. Results: Six RCTs involving 4501 cardiac surgery patients were included. AA mixture interventions significantly reduced the risk of AKI stage 1 (RR: 0.56; 95% CI: 0.77–0.96; p =.009; CoE: Moderate) and Stage 3 (RR: 0.53; 95% CI: 0.34–0.83; p =.005; CoE: Moderate), but not stage 2 (RR: 1.24; 95% CI: 0.60–2.55; p =.568; CoE: Low). Preliminary findings from glutamic acid and glutamine (single AA interventions) showed potential benefits in reducing AKI incidence (CoE: Very low) and improving surrogate biomarkers, respectively. No significant effects were observed on mortality or RRT incidence for any intervention. Conclusion: AA mixtures likely reduce AKI incidence following cardiac surgery but show limited effects on mortality and RRT. Further trials are needed to confirm the benefits of glutamic acid and glutamine supplementation. Editorial Comment: Use of amino acid supplementation for the prevention of acute kidney injury after cardiac surgery may be effective, but more trial data and confidence in a beneficial effect is needed for this to be implemented in everyday clinical practice.Type
info:eu-repo/semantics/articleRights
info:eu-repo/semantics/restrictedAccessLanguage
engISSN
00015172EISSN
13996576ae974a485f413a2113503eed53cd6c53
https://doi.org/10.1111/aas.70037
Scopus Count
Collections
